India markets open in 4 hours 42 minutes
  • BSE SENSEX

    49,206.47
    +256.67 (+0.52%)
     
  • Nifty 50

    14,823.15
    +98.35 (+0.67%)
     
  • Dow

    34,777.76
    +229.26 (+0.66%)
     
  • Nasdaq

    13,752.24
    +119.44 (+0.88%)
     
  • BTC-INR

    4,255,843.00
    -36,674.50 (-0.85%)
     
  • CMC Crypto 200

    1,480.07
    +44.29 (+3.08%)
     
  • Hang Seng

    28,610.65
    -26.85 (-0.09%)
     
  • Nikkei

    29,357.82
    +26.42 (+0.09%)
     
  • EUR/INR

    89.1883
    +0.3800 (+0.43%)
     
  • GBP/INR

    102.7909
    +0.5539 (+0.54%)
     
  • AED/INR

    19.9130
    -0.0780 (-0.39%)
     
  • INR/JPY

    1.4783
    -0.0011 (-0.07%)
     
  • SGD/INR

    55.3280
    +0.1220 (+0.22%)
     

TechInvention partners Eubiologics to bring oral cholera vaccine to India

·1-min read

New Delhi, Mar 26 (PTI) TechInvention Lifecare has tied up with South Korea-based biopharmaceutical firm Eubiologics Co Ltd for bringing in oral cholera vaccine 'Euvichol-Plus' to India.

The vaccine is prequalified by the World Health Organization (WHO), TechInvention Lifecare Pvt Ltd said in a statement.

Eubiologics has so far supplied 55 million doses to UN healthcare agencies. Euvichol-Plus has been supplied to around 22 countries across the globe, it added.

'It is our endeavour to bring in a WHO prequalified oral cholera vaccine (OCV) in India for managing potential outbreak risk caused due to the often-neglected disease like cholera,' TechInvention Founder and CEO Syed Ahmed said.

In a similar vein, Eubiologics Co CEO Yeong-Ok Baik said, 'The collaboration between Eubiologics and Techinvention is aimed at reducing the disease burden and saving lives of Indian children by effective vaccination through our WHO-prequalified cholera vaccine, Euvichol-Plus in a unidose pack.' PTI AKT RUJ RUJ